Compound 1599
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccccc2C(C)(C)C)c1=O
- InChi:
InChI=1S/C25H22F3N5O/c1-24(2,3)17-10-5-6-11-18(17)33-23(34)19-20(14-8-7-9-15(12-14)25(26,27)28)30-22-16(21(19)31-33)13-29-32(22)4/h5-13,31H,1-4H3
- InChiKey:
SKLGYHOMBPPXCH-UHFFFAOYSA-N
External links
![]() 168317808 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.05 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 465.18 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 6.54 | |||
TPSA | 63.05 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4933 | ATX-914 | DB12673 | |
0.4677 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4655 | Tepotinib | DB15133 | |
0.4622 | Decoglurant | DB11923 | |
0.4568 | Riociguat | DB08931 | |
0.4502 | Ravoxertinib | DB15281 | |
0.4496 | Risdiplam | DB15305 | |
0.4474 | MK-1775 | DB11740 | |
0.4465 | MK-0249 | DB11910 | |
0.4436 | TAS-116 | DB14876 | |
0.4422 | Vericiguat | DB15456 | |
0.4409 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4380 | 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE | DB07606 | |
0.4364 | Dilmapimod | DB12140 | |
0.4339 | 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL | DB07712 |